Login to Your Account

Cevec Gets €4M to Develop Protein Production Platform

By Cormac Sheridan

Wednesday, November 4, 2009

No Abstract


BioWorld International Correspondent

Cevec Pharmaceuticals GmbH raised €4 million (US$5.9 million) in new funding to support the commercialization of its proprietary protein expression platform CAP, which the company is positioning as a high-yield technology for the production of complex proteins.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription